LEVANT 2 Safety Registry

NACompletedINTERVENTIONAL
Enrollment

1,189

Participants

Timeline

Start Date

July 20, 2011

Primary Completion Date

November 27, 2015

Study Completion Date

November 1, 2018

Conditions
Peripheral Artery DiseaseFemoropopliteal Artery OcclusionFemoropopliteal Stenosis
Interventions
DEVICE

Lutonix Drug Coated Balloon

Use of the Lutonix Drug Coated Balloon (DCB) for the treatment of stenosis or occlusion of the femoropopliteal arteries.

DEVICE

Standard PTA Balloon

Use of Standard PTA Balloon in the treatment of stenosis or occlusion of the femoropopliteal arteries.

Trial Locations (8)

10021

New York Presbyterian Hospital/Weill Cornell Medical Center, New York

39216

Jackson Heart Clinic/St. Dominic's Hospital, Jackson

45220

TriHealth Heart Institute, Cincinnati

49519

Metro Health Hospital, Wyoming

65804

Mercy Hospital, Springfield

78130

Mission Research Institute, New Braunfels

94538

Mission Cardiovascular Research Institute, Fremont

07666

Holy Name Medical Center, Teaneck

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT01790243 - LEVANT 2 Safety Registry | Biotech Hunter | Biotech Hunter